| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00213-005-0025-4 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s00213-005-0025-4 |
| P698 | PubMed publication ID | 15983790 |
| P5875 | ResearchGate publication ID | 7759675 |
| P50 | author | Christine M. Tipper | Q41046395 |
| Todd Woodward | Q43174947 | ||
| P2093 | author name string | Peter F Liddle | |
| Anthony G Phillips | |||
| Elton T C Ngan | |||
| Tara A Cairo | |||
| P2860 | cites work | Effects of bromocriptine on human subjects depend on working memory capacity. | Q48565561 |
| Intravenous dextroamphetamine and brain glucose metabolism. | Q48586889 | ||
| Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. | Q48617067 | ||
| Neuropsychological function in nonpsychotic unipolar major depression. | Q48702663 | ||
| Cerebral glucose metabolism during pharmacologic studies: test-retest under placebo conditions. | Q48968488 | ||
| Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. | Q51375205 | ||
| The influence of working memory load on phase specific patterns of cortical activity. | Q51936135 | ||
| Changes in distributed neural circuitry function in patients with first-episode schizophrenia. | Q51998196 | ||
| Self-monitoring cognitive performance during sleep deprivation: effects of modafinil, d-amphetamine and placebo. | Q52000728 | ||
| Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. | Q52003803 | ||
| Working memory dysfunction in major depression: an event-related potential study. | Q52024885 | ||
| Effects of methylphenidate on spatial working memory and planning in healthy young adults. | Q52042971 | ||
| Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. | Q52051956 | ||
| Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. | Q52056465 | ||
| Effects of dextroamphetamine on cognitive performance and cortical activation. | Q52166001 | ||
| Pharmacologic strategies for augmenting cognitive performance in schizophrenia. | Q52180294 | ||
| Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation | Q73556216 | ||
| Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects | Q22248075 | ||
| Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia | Q29614929 | ||
| Neurochemical brain imaging investigations of schizophrenia | Q30581142 | ||
| The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia | Q33644000 | ||
| Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies | Q33833648 | ||
| Regional cerebral blood flow response to oral amphetamine challenge in healthy volunteers. | Q33945556 | ||
| Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia | Q33957624 | ||
| Chemical neuromodulation of frontal-executive functions in humans and other animals. | Q33995928 | ||
| Effects of tyrosine, phentermine, caffeine D-amphetamine, and placebo on cognitive and motor performance deficits during sleep deprivation | Q34217920 | ||
| Dextroamphetamine enhances "neural network-specific" physiological signals: a positron-emission tomography rCBF study. | Q34393163 | ||
| Dose-dependent effects of the dopamine D1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys. | Q34442877 | ||
| Catechol O -methyltransferase val 158 -met genotype and individual variation in the brain response to amphetamine | Q35023131 | ||
| Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment | Q35611010 | ||
| Adrenergic targets for the treatment of cognitive deficits in schizophrenia | Q35810047 | ||
| Catecholamine modulation of prefrontal cortical cognitive function | Q37827944 | ||
| Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey | Q39680193 | ||
| Magnitude of dopamine release in medial prefrontal cortex predicts accuracy of memory on a delayed response task. | Q40537900 | ||
| Working memory dysfunction in schizophrenia | Q40582842 | ||
| 6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze | Q41193630 | ||
| The role of serotonin in the pathophysiology and treatment of schizophrenia | Q41337912 | ||
| Distinct contributions of glutamate and dopamine receptors to temporal aspects of rodent working memory using a clinically relevant task | Q43555258 | ||
| An fMRI study of the effect of amphetamine on brain activity | Q43828280 | ||
| Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C]raclopride study in healthy men. | Q44237570 | ||
| Enhancement of working memory in aged monkeys by a sensitizing regimen of dopamine D1 receptor stimulation. | Q44762687 | ||
| D1 Dopamine Receptors in Prefrontal Cortex: Involvement in Working Memory | Q45191426 | ||
| Glutamatergic and dopaminergic afferents to the prefrontal cortex regulate spatial working memory in rats | Q48171480 | ||
| Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography | Q48250808 | ||
| Capacity limitations in short-term memory in schizophrenia: tests of competing hypotheses. | Q48449782 | ||
| Dopamine and the mechanisms of cognition: Part II. D-amphetamine effects in human subjects performing a selective attention task. | Q48459137 | ||
| Noise stress impairs prefrontal cortical cognitive function in monkeys: evidence for a hyperdopaminergic mechanism. | Q48485543 | ||
| D1- versus D2-receptor modulation of visuospatial working memory in humans. | Q48493267 | ||
| D1 receptor modulation of hippocampal-prefrontal cortical circuits integrating spatial memory with executive functions in the rat. | Q48514054 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 634-643 | |
| P577 | publication date | 2005-08-01 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | Processing efficiency of a verbal working memory system is modulated by amphetamine: an fMRI investigation | |
| P478 | volume | 180 |
| Q34017591 | A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment |
| Q35851490 | Amphetamine Exerts Dose-Dependent Changes in Prefrontal Cortex Attractor Dynamics during Working Memory. |
| Q34575194 | Amphetamine increases errors during episodic memory retrieval |
| Q48156032 | An fMRI study of prefrontal brain activation during multiple tasks in patients with major depressive disorder |
| Q39837691 | An investigation into aripiprazole's partial D₂ agonist effects within the dorsolateral prefrontal cortex during working memory in healthy volunteers |
| Q36666847 | Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals |
| Q51980372 | C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency. |
| Q48228040 | Differential effects of the D- and L- isomers of amphetamine on pharmacological MRI BOLD contrast in the rat. |
| Q43983178 | Factor structure of the Norwegian version of the WAIS-III in a clinical sample: the arithmetic problem |
| Q34172681 | Nondependent stimulant users of cocaine and prescription amphetamines show verbal learning and memory deficits |
| Q36677757 | Pre-encoding administration of amphetamine or THC preferentially modulates emotional memory in humans |
| Q37262032 | Sleep deprivation decreases binding of [11C]raclopride to dopamine D2/D3 receptors in the human brain. |
| Q38826210 | True alignment of preclinical and clinical research to enhance success in CNS drug development: a review of the current evidence |
Search more.